A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1523-1527

  Hayashi, Jun ^a   Furusyo, Norihiro ^a   Ariyama, Iwao ^a   Sawayama, Yasunori ^a   Etoh, Yoshitaka ^a   Kashiwagi, Seizaburo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ARTICLE; FEMALE; GENE MUTATION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS VIRUS NON A NON B; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS GENE;

ADULT; AGED; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; JAPAN; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RNA, VIRAL; VARIATION (GENETICS); VIREMIA;

EID: 0034129540     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315431     Document Type: Article

References (28)

1. 1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244: 362-4.
2. 2. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibody to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;8670: 1006-8.
3. 3. Hayashi J, Kishihara Y, Yamaji K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995;90:794-9.
4. 4. Prieto M, Olaso V, Verdu C, et al. Does the healthy hepatitis C virus carrier state really exist? Hepatology 1995;22:413-7.
5. 5. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-83.
6. 6. Dienes HP, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology 1982;2:562-71.
7. 7. Alberti A, Morsica G, Chemello L, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-8.
8. 8. Cerney A, McHutchison JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995;95:521-30.
9. 9. Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus-associated fulminant hepatitis failure. N Engl J Med 1996;335:631-4.
10. 10. Hayashi J, Kishihara Y, Yamaji K, et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997;25:697-701.
11. 11. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
12. 12. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
13. 13. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for nomenclature of genotypes for hepatitis C virus. Hepatology 1994;19:1321-4.
14. 14. Sherman KE, O'Brien J, Gutierrez AG, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993;31:2679-82.
15. 15. Gordon SC, Kodali VP, Silverman AL, et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994;89:1458-61.
16. 16. Hayashi J, Kishihara Y, Yoshimura E, et al. Relationship of genotype to level of hepatitis C viraemia determined by competitive polymerase chain reaction. J Infect 1995;30:235-9.
17. 17. Hayashi J, Yoshimura E, Kishihara Y, et al. Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR. Am J Gastroenterol 1996;91:314-8.
18. 18. Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997;26:1393-8.
19. 19. Luo JC, Hwang SJ, Lai CR, et al. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. J Gastroenterol Hepatol 1998;13:685-90.
20. 20. Furusyo N, Hayashi J, Sawayama Y, Kishihara Y, Kashiwagi S. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long term follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg 1999;60:616-22.
21. 21. Kurosaki M, Enomoto N, Marumo F, Sato C. Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis. Arch Virol 1995;140:1087-94.
22. 22. Kita H, Hiroishi K, Moriyama T, et al. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J Gen Virol 1995;76: 3189-93.
23. 23. Weiner AJ, Ericken AL, Kansopon J, et al. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp 1995;25:227-35.
24. 24. Nishiguchi S, Kuroki T, Nakatani S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
25. 25. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-5.
26. 26. Shibata M, Morizane T, Uchida T, et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 1998;351:1773-7.
27. 27. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995;345:413-5.
28. 28. Hayashi J, Kishihara Y, Ueno K, et al. Age-related response to interferon alfa treatment in women vs. men with chronic hepatitis C virus infection. Arch Intern Med 1998;158:177-81.